Cancer cells resistant to treatment are already present before diagnosis of adult leukaemia

by IRB Barcelona - Instituto de Investigación Biomédica

This work is a collaboration between Núria López-Bigas’ lab at IRB Barcelona and the groups headed by Anna Bigas (Hospital del Mar Medical Research Institute) and Josep Maria Ribera (Josep Carrera...

Read more

ORYZON holds its 4th annual Solidarity Day

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, celebrated yest...

Read more

ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces the p...

Read more

Immuneel Therapeutics, Hospital Clínic de Barcelona & IDIBAPS Announce a Strategic collaboration & a License Agreement

by Fundació Clínic per a la Recerca Biomèdica

Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Hospital Clínic de Barcelona (HCB) and Institut d’...

Read more

Artificial intelligence, a new tool against leukemia

by Hospital Universitari de Bellvitge

Dr. Carolina M. Florian project has been selected by La Caixa Health Research grants

Read more

The Josep Carreras Institute creates a spin-off to develop therapies for leukaemia based on CAR–T

by Invivo Capital

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics (OCI)...

Read more

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells

by Hospital Universitari de Bellvitge

At first glance, a one-millimeter worm that needs to be observed with a magnifying glass does not resemble a human being at all. However, the nematode Caenorhabditis elegans, an animal model widely us...

Read more

Rounds of funding, grants, pipeline advances, appointments and discoveries in leukemia

by Biocat

Rounds at Ability, Elma and Vytrus and “la Caixa” grants, among the top headlines in September

Read more

The group of hematological neoplasms and hematopoietic transplantation of the IDIVAL published a study that linked high levels of the FANCA gene with a worse prognosis in chronic lymphatic leukemia

by Instituto de Investigación Marqués de Valdecilla

Chronic Lymphatic Leukemia (CLL) is the most common type of leukemia in adults in the West. It mainly affects elderly patients and its incidence is expected to increase due to the progressive increase...

Read more

New immunotherapeutic strategy to treat T-cell acute lymphoblastic leukemia

by IrsiCaixa

The study uses genetically modified immune cells that specifically target the CD1a molecule of the tumour cells, suggesting a new treatment with less adverse effects for patients

Read more

ORYZON to Present Clinical Data on LSD1 Inhibitor ORY-1001 at ASH 2016

by Oryzon Genomics

ORY - 1001 (RG6016), Oryzon’s first clinical asset, is a highly potent and selective Lysine Specific Demethylase - 1 (LSD1) inhibitor for the treatment of leukemia and other malignancies, currently ...

Read more

Mutations in the dark side of the genome cause leukemia

by Fundació Clínic per a la Recerca Biomèdica

Dr. Lopez-Otin comments: “The most relevant finding of this study has been the identification of mutations in regions of the genome which do not code for proteins and whose functional relevance is s...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Un hidrogel inyectado puede promover la ...

by DiCYT - Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología

El Grupo BIOFORGE de la UVa publica en la prestigiosa revista 'Science...

Photos Stream